BaseSpace
Correlation Engine 2.0
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. Arthritis, Hypothalamus, Amniocentesis, Valproic acid, rs4950928, DRD2)
Bookmark Forward

QuickView for plasminogen activation (biogroup)


Body Atlas

Most Correlated Tissues

  1. Fetal liver
  2. Liver
  3. Kidney
  4. Kidney cortex
  5. Fetal lung
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alpha-1-antitrypsin deficiency
  2. Acute hepatic failure
  3. Hepatic failure
  4. Liver cancer
  5. Tularemia
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. CP 724714
  2. niguldipine
  3. Silver Nanoparticles
  4. Trichloroepoxypropane
  5. tetrafluoroethylene
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR20B
  2. ANKS6
  3. PNPLA3
  4. RPIA
  5. UNC93B1
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

  1. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (1 of 2)
  2. L1000 CMAP - Hepatocellular carcinoma Hep G2 cells with shRNA-mediated gene knockdown (2 of 2)
  3. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
  4. L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
  5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. The plasminogen activation system: new targets in lung inflammation and remodeling.
  2. The plasminogen activation system modulates differently adipogenesis and myogenesis of embryonic ste…
  3. Serum amyloid A enhances plasminogen activation: implication for a role in colon cancer.
  4. Peptides and small molecules targeting the plasminogen activation system: towards prophylactic anti-…
  5. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-t…
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. Diurnal Variation of Plasminogen Activator Inhibitor-1
  2. Intraventricular Tissue Plasminogen Activator (tPA) in the Management of Aneurysmal Subarachnoid Hem…
  3. Assessment of the Soluble Urokinase Plasminogen Activator Receptor in Non-cardiac Surgery (SPARSE)
  4. Injection of Recombinant Human Tissue-type Plasminogen Activator Derivative for Acute Pulmonary Embo…
  5. Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Isch…
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.